This educational activity will provide healthcare professionals with an update on recent advances in the diagnosis, classification, and management of immune-mediated inflammatory diseases, including psoriasis, psoriatic arthritis, atopic dermatitis, vitiligo, alopecia areata, and hidradenitis suppurativa. Through expert presentations, case-based discussions, and interactive panels, participants will examine emerging biologic and small-molecule therapies, evolving regulatory indications, immune-system targets, and relevant evidence regarding disease pathophysiology and immunology. The program will also address common comorbidities associated with these conditions and review the safety, efficacy, and toxicity of available and emerging treatments. Emphasis will be placed on practical strategies for selecting appropriate therapies and anticipating, preventing, and managing treatment-related adverse effects and complications.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 1301 Virginia Drive
Pricing
CME included with membership
| Free Registration | Free |
| Tufts-Affiliated HCP - Early Bird (by 10/5/26) | $75 |
| Tufts-Affiliated HCP - Standard | $175 |
| Trainees & Allied Health - Early Bird (by 10/5/26) | $75 |
| Trainees & Allied Health - Standard | $175 |
| Physicians - Early Bird (by 10/5/26) | $150 |
+3 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Pediatrics
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Neurology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Regularly Scheduled Series
- Credit · Up to 6.5 credits
-
ReleasedMay 2, 2026
-
Last day to claim creditDec 4, 2026 7 weeks left
-
Med Learning Group TYK, Tock Time to Rethink PsA Management: Exploring the Potential Role of Emerging Oral Therapies
-
Answers in CME Inc. (AiCME) Beyond Biologics for Psoriasis and PsA: TYK2 Inhibitors and Practical Considerations for Personalizing Care
-
National Association for Continuing Education Responding to the Science Biologics in Practice in COPD
-
Global Learning Collaborative From Disease Assessment to Advanced Therapy: A Practical Framework for Atopic Dermatitis
-
Global Learning Collaborative Beyond Checkpoint Blockade in SCLC: Emerging Antigen Targets and Treatment Strategies Across Disease Stages
-
Global Learning Collaborative Pruritus In PN and AD: Challenge How You Manage Itch
